Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Isolated Gastrocnemius Tightness and Tactile Sensitivity

14 september 2026 bijgewerkt door: Rabia ZORLULAR, Nigde Omer Halisdemir University

Plantar Tactile Sensitivity Individuals With Isolated Gastrocnemius Tightness

Isolated gastrocnemius tightness is associated with various foot pathologies, particularly metatarsalgia and hallux valgus, and is also commonly observed in the general population. Limited ankle dorsiflexion, typically resulting from tightness of the gastrocnemius-soleus complex, may alter normal gait mechanics and lead to compensatory movement patterns that increase mechanical stress on the lower extremity. It is planned to include a total of 40 participants in this study: 20 individuals with isolated gastrocnemius tightness and 20 without. The participants' plantar tactile sensitivity and postural control characteristics will be compared.

Studie Overzicht

Toestand

Aanmelden op uitnodiging

Gedetailleerde beschrijving

Isolated gastrocnemius tightness has been widely studied in the adult population and associated with various foot and ankle pathologies, such as plantar fasciitis, plantar ulcers, Achilles tendinopathy, pes planus, and posterior tibial tendon dysfunction. However, no study evaluating plantar tactile sensation in individuals with isolated gastrocnemius tightness has been found in the existing literature. The findings of this study are expected to contribute to the existing literature regarding the relationship between isolated gastrocnemius tightness and plantar tactile sensation and postural control. Evaluating plantar tactile sensitivity and postural control together may help elucidate not only the mechanical effects of isolated gastrocnemius tightness on joint range of motion but also its potential effects related to sensory and postural control. This study plans to include 40 participants: 20 with isolated gastrocnemius tightness and 20 without. The participants' plantar tactile sensitivity and postural control characteristics will be compared.

Studietype

Observationeel

Inschrijving (Geschat)

40

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

It is planned to include a total of 40 participants in this study: 20 individuals with isolated gastrocnemius tightness and 20 without.

Beschrijving

Inclusion Criteria:

  • Adults aged 18-65 with or without isolated gastrocnemius tightness,
  • Individuals able to walk without experiencing pain

Exclusion Criteria:

  • Presence of neuromuscular disease,
  • Conditions affecting plantar tactile sensation, such as diabetes,
  • History of prior surgical procedures distal to the knee joint,
  • Any current or previous symptoms related to the foot or ankle region,
  • Presence of joint hypermobility,
  • Individuals who do not volunteer.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
individuals with isolated gastrocnemius tightness

The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index (ADI):

•Ankle Dorsiflexion Index = Dorsiflexion with knee at 20° flexion - Dorsiflexion with knee in full extension The threshold value of ADI ≥10°, commonly used in the literature for classifying isolated gastrocnemius tightness, will be taken into account.

First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground.

Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion.

The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index

individuals without isolated gastrocnemius tightness

The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index:

For individuals without isolated gastrocnemius tightness, a threshold value of <10° for the Ankle Dorsiflexion Index will be considered.

First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground.

Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion.

The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Ankle Dorsiflexion Index
Tijdsspanne: 6 months

First, the participant will be asked to move their knee forward-while keeping the heel of the tested foot in full contact with the ground and the foot aligned forward-until reaching the maximum dorsiflexion position possible without the heel lifting off the ground.

Ankle dorsiflexion range of motion will be measured with the knee flexed at a minimum of 20°. Subsequently, the same assessment will be repeated with the knee in full extension (0°). Under both conditions, the maximum angular change occurring during the forward movement of the tibia relative to the starting position will be recorded as the ankle dorsiflexion range of motion.

The difference between the mean dorsiflexion values obtained with the knee flexed at a minimum of 20° and in full extension will be calculated as the Ankle Dorsiflexion Index

6 months
Assessment of postural control
Tijdsspanne: 6 months
Postural control will be assessed using a force plate (KINVENT, France). Data will be transmitted to the force plate application via a Bluetooth connection. Prior to the actual measurements, participants will be informed about the force platform and the test conditions, and a practice trial will be conducted to familiarize them with the tests. Static postural control will be assessed under three different conditions: (1) standing on both feet with eyes open, (2) standing on both feet with eyes closed, and (3) standing on one foot with eyes open. In the assessment of postural control, the primary Center of Pressure parameters-mean Center of Pressure velocity, Center of Pressure path length, and sway area-were evaluated.
6 months
Plantar tactile sensitivity
Tijdsspanne: 6 months
Plantar tactile sensitivity will be assessed using Semmes-Weinstein monofilaments. During the assessment, participants will be positioned prone, with their feet hanging freely off the edge of the examination table and not touching any surface. The assessment will begin with the monofilament that applies the lowest force, and the procedure will progress to progressively thicker monofilaments until the participant perceives the stimulus. The lowest Semmes-Weinstein monofilament value perceived in these areas will be recorded as the plantar tactile sensation threshold. Lower perceived pressure values indicate higher tactile sensitivity in the sole of the participant's foot.
6 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Rabia ZORLULAR, Nigde Omer Halisdemir University

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

30 september 2026

Primaire voltooiing (Geschat)

1 januari 2027

Studie voltooiing (Geschat)

1 januari 2027

Studieregistratiedata

Eerst ingediend

14 september 2026

Eerst ingediend dat voldeed aan de QC-criteria

14 september 2026

Eerst geplaatst (Werkelijk)

18 september 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

18 september 2026

Laatste update ingediend die voldeed aan QC-criteria

14 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • Isolated Gastrocnemius

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren